Genotech제노텍
066830 · KONEX · ₩066830 · 제노텍
- Market cap
- ₩7.4B
- Enterprise value
- —
- P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- ROE
- —
- Net margin
- —
Financial statements not available yet. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−18.9% from the high
₩805Today: ₩1,298 – ₩1,298₩1,600
Returns
- 1W+8.3%
- 1M+8.2%
- 3M+8.3%
- 6M+8.4%
- YTD+19.2%
- 1Y+21.6%
- Volume today
- —
- Traded today
- —
- Listed shares
- 5,667,180
- EPS (12 months)
- —
🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 28 of 100 (50 is a normal day for this stock).
- MomentumStrong10% over the last month; the price is above its 20-day average.
- News impactLow1 news items and filings in two weeks; 0 rated high impact, 0 medium.
Signals describe activity, not recommendations. Not financial advice.
Genotech stock overview
Genotech (제노텍, KRX: 066830) is listed on KONEX, in the Chemicals sector. The company develops and sells life science research tools centered on genes, including synthetic oligonucleotides (synthetic DNA) used in molecular biology research and gene-based diagnostic kits. Its shares closed at ₩1,298 on Oct 30, 2026, unchanged on the day, giving it a market value of ₩7.4B.
Key facts
- Market cap
- ₩7.4B
- Sector
- Chemicals
- Latest price change
- 0.00%
- As of
- Oct 30, 2026
- Main business
- The company develops and sells life science research tools centered on genes, including synthetic oligonucleotides (synthetic DNA) used in molecular biology research and gene-based diagnostic kits.
Quick answers about Genotech
- What does Genotech do?
- The company develops and sells life science research tools centered on genes, including synthetic oligonucleotides (synthetic DNA) used in molecular biology research and gene-based diagnostic kits. It also provides DNA sequencing and bio-research services, mainly to universities, government and research institutes, hospitals and biotech companies. Its main sales areas are the Seoul metropolitan area and Daejeon, with distributors covering other regions in South Korea.
- What is the market cap of Genotech?
- The market capitalisation of Genotech was ₩7.4B at the close on Oct 30, 2026.
- Who are the largest shareholders of Genotech?
- According to the latest official filings, the largest reported holders are Kim Jae-jong (48.36%, as of Mar 26, 2025); Korea Investment Partners (2.73%, as of Feb 9, 2026); Lee In-jae (0.19%, as of Feb 5, 2026).
- When is the next earnings report from Genotech?
- Korean companies rarely announce results dates in advance. Based on when Genotech filed the same report in past years, its next annual results is expected between Mar 13, 2027 and Mar 15, 2027.
Company profile
The company develops and sells life science research tools centered on genes, including synthetic oligonucleotides (synthetic DNA) used in molecular biology research and gene-based diagnostic kits. It also provides DNA sequencing and bio-research services, mainly to universities, government and research institutes, hospitals and biotech companies. Its main sales areas are the Seoul metropolitan area and Daejeon, with distributors covering other regions in South Korea.
Written by AI from the company's latest annual report.
- Korean name
- 제노텍
- Sector
- Chemicals
- Themes
- —
- CEO
- 김재종
- Founded
- Jul 1997
- Listed
- Jul 2016
- Listed shares
- 5,667,180
- Fiscal year ends
- Month 12
- Website
- www.genotech.co.kr
Similar companies
- LG Chem051910 · ₩17T₩235,000+0.43%
- Hanwha Solutions009830 · ₩5.1T₩22,600−4.24%
- Hanwha000880 · ₩4.7T₩88,700−3.48%
- SKC011790 · ₩3.5T₩71,500−1.92%
- KCC002380 · ₩3.3T₩389,500−2.14%
- Kumho Petro Chemical011780 · ₩2.7T₩106,700+0.38%
- Soulbrain357780 · ₩2.3T₩301,000−3.99%
- Hansol Chemical014680 · ₩2.3T₩211,500−2.76%
Recent filings
See all- Investor relations (IR) eventOct 27, 2026
- Investor relations (IR) eventMay 14, 2026
- Investor relations (IR) eventApr 27, 2026
- Annual general meeting resultsMar 23, 2026
- Annual report (Dec 2025)Mar 13, 2026
Titles in Korean until English translations are added.
Also known as: Genotech / 제노텍 / 066830 / KRX:066830
Source: KRX statistical information